• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Metastatic disease in head & neck oncology.

作者信息

Pisani Paolo, Airoldi Mario, Allais Anastasia, Aluffi Valletti Paolo, Battista Mariapina, Benazzo Marco, Briatore Roberto, Cacciola Salvatore, Cocuzza Salvatore, Colombo Andrea, Conti Bice, Costanzo Alberto, Della Vecchia Laura, Denaro Nerina, Fantozzi Cesare, Galizia Danilo, Garzaro Massimiliano, Genta Ida, Iasi Gabriela Alejandra, Krengli Marco, Landolfo Vincenzo, Lanza Giovanni Vittorio, Magnano Mauro, Mancuso Maurizio, Maroldi Roberto, Masini Laura, Merlano Marco Carlo, Piemonte Marco, Pisani Silvia, Prina-Mello Adriele, Prioglio Luca, Rugiu Maria Gabriella, Scasso Felice, Serra Agostino, Valente Guido, Zannetti Micol, Zigliani Angelo

机构信息

ENT Unit, ASL AT, "Cardinal Massaja" Hospital, Asti, Italy.

Medical Oncology, Città della Salute e della Scienza, Torino, Italy.

出版信息

Acta Otorhinolaryngol Ital. 2020 Apr;40(SUPPL. 1):S1-S86. doi: 10.14639/0392-100X-suppl.1-40-2020.

DOI:10.14639/0392-100X-suppl.1-40-2020
PMID:32469009
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7263073/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5373/7263073/692f62165830/aoi-2020-02-S1-g016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5373/7263073/93fcc6ef6120/aoi-2020-02-S1-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5373/7263073/35b24bf8e8c3/aoi-2020-02-S1-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5373/7263073/09812756b1c8/aoi-2020-02-S1-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5373/7263073/19dec08dea91/aoi-2020-02-S1-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5373/7263073/57e37402f869/aoi-2020-02-S1-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5373/7263073/cc1b0fceb185/aoi-2020-02-S1-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5373/7263073/af56dfdb6bde/aoi-2020-02-S1-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5373/7263073/fa9bc629c02d/aoi-2020-02-S1-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5373/7263073/4dcf531c2489/aoi-2020-02-S1-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5373/7263073/b777f86b988b/aoi-2020-02-S1-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5373/7263073/9ef7c9510cc1/aoi-2020-02-S1-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5373/7263073/bc8a4300e7c4/aoi-2020-02-S1-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5373/7263073/0ce29b183e48/aoi-2020-02-S1-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5373/7263073/f2f6b5bd26f8/aoi-2020-02-S1-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5373/7263073/690058da1de4/aoi-2020-02-S1-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5373/7263073/692f62165830/aoi-2020-02-S1-g016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5373/7263073/93fcc6ef6120/aoi-2020-02-S1-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5373/7263073/35b24bf8e8c3/aoi-2020-02-S1-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5373/7263073/09812756b1c8/aoi-2020-02-S1-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5373/7263073/19dec08dea91/aoi-2020-02-S1-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5373/7263073/57e37402f869/aoi-2020-02-S1-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5373/7263073/cc1b0fceb185/aoi-2020-02-S1-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5373/7263073/af56dfdb6bde/aoi-2020-02-S1-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5373/7263073/fa9bc629c02d/aoi-2020-02-S1-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5373/7263073/4dcf531c2489/aoi-2020-02-S1-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5373/7263073/b777f86b988b/aoi-2020-02-S1-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5373/7263073/9ef7c9510cc1/aoi-2020-02-S1-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5373/7263073/bc8a4300e7c4/aoi-2020-02-S1-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5373/7263073/0ce29b183e48/aoi-2020-02-S1-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5373/7263073/f2f6b5bd26f8/aoi-2020-02-S1-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5373/7263073/690058da1de4/aoi-2020-02-S1-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5373/7263073/692f62165830/aoi-2020-02-S1-g016.jpg

相似文献

1
Metastatic disease in head & neck oncology.头颈部肿瘤学中的转移性疾病
Acta Otorhinolaryngol Ital. 2020 Apr;40(SUPPL. 1):S1-S86. doi: 10.14639/0392-100X-suppl.1-40-2020.
2
HPV and EBV Infections in Neck Metastases from Occult Primary Squamous Cell Carcinoma: Another Virus-Related Neoplastic Disease in the Head and Neck Region.隐匿性原发性鳞状细胞癌颈部转移灶中的人乳头瘤病毒和EB病毒感染：头颈部区域的另一种病毒相关肿瘤性疾病
Ann Surg Oncol. 2015 Dec;22 Suppl 3:S979-84. doi: 10.1245/s10434-015-4808-5. Epub 2015 Aug 19.
3
Treatment Strategy for Distant Synchronous Metastatic Head and Neck Squamous Cell Carcinoma.远处同步转移性头颈部鳞状细胞癌的治疗策略。
Curr Oncol Rep. 2019 Nov 14;21(11):102. doi: 10.1007/s11912-019-0856-5.
4
Survival After Distant Metastasis in Head and Neck Cancer.头颈部癌远处转移后的生存情况
Anticancer Res. 2015 Oct;35(10):5499-502.
5
Patterns of recurrence in head and neck squamous cell carcinoma to inform personalized surveillance protocols.头颈部鳞状细胞癌复发模式，为制定个体化监测方案提供信息。
Cancer. 2023 Sep 15;129(18):2817-2827. doi: 10.1002/cncr.34823. Epub 2023 May 10.
6
[Outcome and prognostic factors of 125 loco-regionally advanced head and neck squamous cell carcinoma treated with multi-modality treatment].[125例局部晚期头颈部鳞状细胞癌多模态治疗的疗效及预后因素]
Zhonghua Zhong Liu Za Zhi. 2014 Mar;36(3):217-22.
7
Distant metastases in head and neck cancer.头颈部癌的远处转移
Head Neck. 2017 Sep;39(9):1733-1743. doi: 10.1002/hed.24687. Epub 2017 Jun 26.
8
Viral and Clinical Oncology of Head and Neck Cancers.头颈部癌症的病毒与临床肿瘤学。
Curr Oncol Rep. 2022 Jul;24(7):929-942. doi: 10.1007/s11912-022-01263-7. Epub 2022 Mar 26.
9
Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.喉和下咽鳞状细胞癌的区域转移延迟、远处转移及第二原发性恶性肿瘤
Laryngoscope. 2001 Jun;111(6):1079-87. doi: 10.1097/00005537-200106000-00028.
10
Brain metastasis from squamous cell carcinoma of the head and neck: a review of the literature in the genomic era.脑转移来自头颈部鳞状细胞癌：基因组时代文献复习。
Neurosurg Focus. 2018 Jun;44(6):E11. doi: 10.3171/2018.2.FOCUS17761.

引用本文的文献

1
Machine Learning-Based Classification of Cervical Lymph Nodes in HNSCC: A Radiomics Approach with Feature Selection Optimization.基于机器学习的头颈部鳞状细胞癌颈淋巴结分类：一种具有特征选择优化的放射组学方法
Cancers (Basel). 2025 Aug 20;17(16):2711. doi: 10.3390/cancers17162711.
2
Mandibular metastasis of invasive ductal carcinoma of the breast: a case report.乳腺浸润性导管癌下颌骨转移：一例报告
J Med Case Rep. 2025 Aug 21;19(1):423. doi: 10.1186/s13256-025-05499-2.
3
Extensive Muscular and Subcutaneous Metastases in Moderately Differentiated Squamous Cell Carcinoma of the Tongue: A Case Report.

本文引用的文献

1
[Perioperative strategies: taking care of the elderly patient with severe advanced comorbidities needing acute surgery.].[围手术期策略：照顾患有严重晚期合并症且需要急症手术的老年患者。]
Recenti Prog Med. 2021 Apr;112(4):250-261. doi: 10.1701/3584.35684.
2
Design of functional electrospun nanofibers for cancer cell capture applications.用于癌细胞捕获应用的功能性电纺纳米纤维的设计
J Mater Chem B. 2018 Mar 14;6(10):1420-1432. doi: 10.1039/c7tb03347h. Epub 2018 Feb 15.
3
Response to salvage chemotherapy after progression on immune checkpoint inhibitors in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck.
舌中分化鳞状细胞癌广泛肌肉及皮下转移：一例报告
Cureus. 2025 Jul 13;17(7):e87825. doi: 10.7759/cureus.87825. eCollection 2025 Jul.
4
Inflammation and limited adaptive immunity predict worse outcomes on immunotherapy in head and neck cancer.炎症和有限的适应性免疫预示着头颈癌免疫治疗的预后更差。
NPJ Precis Oncol. 2025 Aug 5;9(1):272. doi: 10.1038/s41698-025-01020-6.
5
H3 lysine 18 lactylation-mediated RRAS2 facilitates migration and invasion of head and neck squamous cell carcinoma.H3赖氨酸18乳酰化介导的RRAS2促进头颈部鳞状细胞癌的迁移和侵袭。
Sci Rep. 2025 Jul 1;15(1):21282. doi: 10.1038/s41598-025-04233-8.
6
CD18 and CD36 expression in neutrophils from tumors and tumor-draining lymph nodes: implications for metastasis in oral squamous cell carcinoma.肿瘤及肿瘤引流淋巴结中中性粒细胞的CD18和CD36表达：对口腔鳞状细胞癌转移的影响
Clin Exp Metastasis. 2025 Jun 23;42(4):37. doi: 10.1007/s10585-025-10356-z.
7
Time toxicity of nivolumab in metastatic head and neck squamous cell carcinoma patients: a single-institution experience.纳武利尤单抗在转移性头颈部鳞状细胞癌患者中的时间毒性：单机构经验
Immunotherapy. 2025 Jun;17(8):577-583. doi: 10.1080/1750743X.2025.2518913. Epub 2025 Jun 13.
8
Immunotherapy Utilization Outcomes in Distantly Metastatic Head and Neck Squamous Cell Carcinoma.远处转移性头颈部鳞状细胞癌的免疫治疗应用结果
JAMA Otolaryngol Head Neck Surg. 2025 Jun 5. doi: 10.1001/jamaoto.2025.1351.
9
Dual blockage of P-cadherin and c-Met synergistically inhibits the growth of head and neck cancer.P-钙黏蛋白和c-Met的双重阻断协同抑制头颈癌的生长。
Cell Oncol (Dordr). 2025 May 20. doi: 10.1007/s13402-025-01061-w.
10
Advances and challenges in CAR-T cell therapy for head and neck squamous cell carcinoma.头颈部鳞状细胞癌的嵌合抗原受体T细胞（CAR-T）疗法的进展与挑战
Biomark Res. 2025 May 1;13(1):69. doi: 10.1186/s40364-025-00783-1.
针对复发和/或转移性头颈部鳞状细胞癌患者在免疫检查点抑制剂治疗进展后的挽救性化疗的反应。
Eur J Cancer. 2019 Nov;121:123-129. doi: 10.1016/j.ejca.2019.08.026. Epub 2019 Sep 28.
4
Impact of chemotherapy regimen on treatment outcomes in patients with HPV-associated oropharyngeal cancer with T4 disease treated with definitive concurrent chemoradiation.HPV 相关口咽癌 T4 期患者行根治性同步放化疗中化疗方案对治疗结局的影响。
Oral Oncol. 2019 Aug;95:74-78. doi: 10.1016/j.oraloncology.2019.06.007. Epub 2019 Jun 11.
5
Immunotherapy for HPV associated cancer.人乳头瘤病毒相关癌症的免疫疗法。
Papillomavirus Res. 2019 Dec;8:100176. doi: 10.1016/j.pvr.2019.100176. Epub 2019 Jul 13.
6
The promise of combining cancer vaccine and checkpoint blockade for treating HPV-related cancer.将癌症疫苗与检查点阻断联合用于治疗 HPV 相关癌症的前景。
Cancer Treat Rev. 2019 Aug;78:8-16. doi: 10.1016/j.ctrv.2019.07.001. Epub 2019 Jul 5.
7
Hybrid PET/MRI in major cancers: a scoping review.重大癌症的杂交 PET/MRI：范围综述。
Eur J Nucl Med Mol Imaging. 2019 Sep;46(10):2138-2151. doi: 10.1007/s00259-019-04402-8. Epub 2019 Jul 2.
8
Comparative safety and efficacy of anti-PD-1 monotherapy, chemotherapy alone, and their combination therapy in advanced nasopharyngeal carcinoma: findings from recent advances in landmark trials.抗 PD-1 单药治疗、单纯化疗及其联合治疗在晚期鼻咽癌中的比较安全性和疗效：来自标志性试验最新进展的研究结果。
J Immunother Cancer. 2019 Jun 25;7(1):159. doi: 10.1186/s40425-019-0636-7.
9
The failure of cetuximab-based de-intensified regimes for HPV-positive OPSCC: A radiobiologists perspective.基于西妥昔单抗的减强度方案治疗人乳头瘤病毒阳性口咽鳞状细胞癌失败的原因：放射生物学家的观点
Clin Transl Radiat Oncol. 2019 May 22;17:47-50. doi: 10.1016/j.ctro.2019.05.003. eCollection 2019 Jul.
10
Neoadjuvant or Adjuvant Chemotherapy Plus Concurrent CRT Versus Concurrent CRT Alone in the Treatment of Nasopharyngeal Carcinoma: A Study Based on EBV DNA.新辅助化疗或辅助化疗联合同期放化疗与单纯同期放化疗治疗鼻咽癌的比较：基于 EBV DNA 的研究。
J Natl Compr Canc Netw. 2019 Jun 1;17(6):703-710. doi: 10.6004/jnccn.2018.7270.